Kanał LFCR
LF

Lifecore Biomedical, Inc.

LFCR · NASDAQ

$4.48 +1.93% (+$0.09)
1M -1.54%
Market Cap $167.3M
P/E Ratio -
Div. Yield -
ROE 376.95%
Piotroski F-Score Moderate
4/9
Valuation
95 /100
Cheap
P/S 1.36x
P/E N/A
EV/EBITDA N/A
Growth
35 /100
Stable
Rev. growth 5.02%
Book val. growth 75.22%
EPS growth N/A
Profitability
11 /100
Weak
Gross margin 29.68%
Net margin 30.40%
Op. margin 2.12%
Quality
7 /100
Poor
ROIC 1.26%
ROE 376.95%
ROA 16.25%
Debt
43 /100
Moderate
Current ratio 3.87x
Int. coverage -0.46x
Debt/Equity N/A
Stability
40 /100
Moderate
Beta 1.09x
Rev. volatility 16.37%
EPS volatility 319.83%

Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej

Zapytaj StockBota o LFCR
Online

O spółce

Lifecore Biomedical, Inc. (LFCR) is an American biotechnology company specializing in the development and manufacturing of medical devices and biopharmaceutical products. The company is known for its expertise in hyaluronic acid and its medical applications, offering products for ophthalmic surgery, orthopedics, and aesthetic medicine. Lifecore Biomedical focuses on innovation and continuous improvement of its products to meet the highest standards of quality and efficiency. Lifecore Biomedical, Inc. (LFCR) shares could be suitable for investors looking for investments in the biotechnology and medical devices sector with an emphasis on innovative and specialized products.

Opis nie jest jeszcze dostępny w Twoim języku, więc tekst jest po angielsku.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Paul Josephs

Employees

382

Headquarters

Chaska

Nadchodzące wydarzenia

03 LIS

Earnings

Upcoming earnings report

42d

Używamy niezbędnych plików cookie do działania strony oraz opcjonalnych analitycznych plików cookie do pomiaru ruchu. Zobacz naszą Politykę prywatności.